186 related articles for article (PubMed ID: 32729085)
1. MicroRNA Editing Detection and Function: A Combined In Silico and Experimental Approach for the Identification and Validation of Putative Oncogenic Targets.
Tassinari V; Cesarini V; Silvestris DA; Scafidi A; Cucina L; Gallo A
Methods Mol Biol; 2021; 2181():253-267. PubMed ID: 32729085
[TBL] [Abstract][Full Text] [Related]
2. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
Tassinari V; Cesarini V; Silvestris DA; Gallo A
Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
[TBL] [Abstract][Full Text] [Related]
3. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
4. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
Yuting K; Ding D; Iizasa H
Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
[TBL] [Abstract][Full Text] [Related]
5. When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.
Wang Y; Liang H
Bioessays; 2018 Feb; 40(2):. PubMed ID: 29280160
[TBL] [Abstract][Full Text] [Related]
6. Systematic identification of edited microRNAs in the human brain.
Alon S; Mor E; Vigneault F; Church GM; Locatelli F; Galeano F; Gallo A; Shomron N; Eisenberg E
Genome Res; 2012 Aug; 22(8):1533-40. PubMed ID: 22499667
[TBL] [Abstract][Full Text] [Related]
7. The Cancer Editome Atlas: A Resource for Exploratory Analysis of the Adenosine-to-Inosine RNA Editome in Cancer.
Lin CH; Chen SC
Cancer Res; 2019 Jun; 79(11):3001-3006. PubMed ID: 31015229
[TBL] [Abstract][Full Text] [Related]
8. ADAR enzyme and miRNA story: a nucleotide that can make the difference.
Tomaselli S; Bonamassa B; Alisi A; Nobili V; Locatelli F; Gallo A
Int J Mol Sci; 2013 Nov; 14(11):22796-816. PubMed ID: 24256817
[TBL] [Abstract][Full Text] [Related]
9. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
10. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
Gu T; Fu AQ; Bolt MJ; White KP
JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
[TBL] [Abstract][Full Text] [Related]
11. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
Wang Y; Xu X; Yu S; Jeong KJ; Zhou Z; Han L; Tsang YH; Li J; Chen H; Mangala LS; Yuan Y; Eterovic AK; Lu Y; Sood AK; Scott KL; Mills GB; Liang H
Genome Res; 2017 Jul; 27(7):1112-1125. PubMed ID: 28411194
[TBL] [Abstract][Full Text] [Related]
12. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
Nakano M; Fukami T; Gotoh S; Nakajima M
J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
[TBL] [Abstract][Full Text] [Related]
13. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
Kawahara Y; Zinshteyn B; Sethupathy P; Iizasa H; Hatzigeorgiou AG; Nishikura K
Science; 2007 Feb; 315(5815):1137-40. PubMed ID: 17322061
[TBL] [Abstract][Full Text] [Related]
14. A-to-I RNA editing and cancer: from pathology to basic science.
Gallo A; Galardi S
RNA Biol; 2008; 5(3):135-9. PubMed ID: 18758244
[TBL] [Abstract][Full Text] [Related]
15. A-to-I editing of microRNAs in the mammalian brain increases during development.
Ekdahl Y; Farahani HS; Behm M; Lagergren J; Öhman M
Genome Res; 2012 Aug; 22(8):1477-87. PubMed ID: 22645261
[TBL] [Abstract][Full Text] [Related]
16. Adenosine-to-inosine RNA editing meets cancer.
Dominissini D; Moshitch-Moshkovitz S; Amariglio N; Rechavi G
Carcinogenesis; 2011 Nov; 32(11):1569-77. PubMed ID: 21715563
[TBL] [Abstract][Full Text] [Related]
17. Large-scale prediction of ADAR-mediated effective human A-to-I RNA editing.
Yao L; Wang H; Song Y; Dai Z; Yu H; Yin M; Wang D; Yang X; Wang J; Wang T; Cao N; Zhu J; Shen X; Song G; Zhao Y
Brief Bioinform; 2019 Jan; 20(1):102-109. PubMed ID: 28968662
[TBL] [Abstract][Full Text] [Related]
18. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
Liao Y; Jung SH; Kim T
Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming of microRNAs by adenosine-to-inosine editing and the selective elimination of edited microRNA precursors in mouse oocytes and preimplantation embryos.
García-López J; Hourcade Jde D; Del Mazo J
Nucleic Acids Res; 2013 May; 41(10):5483-93. PubMed ID: 23571754
[TBL] [Abstract][Full Text] [Related]
20. RNA Editing in Human and Mouse Tissues.
Srinivasan H; Kok EPL; Tan MH
Methods Mol Biol; 2021; 2181():163-176. PubMed ID: 32729080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
